dihexa clinical trial human trials status Dihexa shows neurotrophic activity exceeding BDNF in preclinical studies DIHEXA | Peptide Synthetic dihexa human clinical trials data

The table below summarizes the practical differences

Molecules 19 (11), 1906619077

Cognitive Impairment Models: Dihexa has been tested in scopolamine-induced amnesia models and aged rat models, where it demonstrated restoration of cognitive performance on spatial memory tasks

They are sometimes referenced together in informal 'Wolverine stack' planning

For non-standard ratios, use separate BPC-157 and TB-500 vials and adjust proportions yourself

Practical and Research Context For researchers and readers using this page as reference material, the compounds sit at similar but not identical points: both are injectable, once-weekly, investigational metabolic peptides with genuine human RCT data a status that already sets them apart from the many research peptides supported only by animal or in-vitro work but neither is an approved medicine, and the two have never been compared directly